Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
CDK4
Cyclin-dependent kinase 4 |
20 |
17 |
Small-scale |
0.992 | High |
|
CDK6
Cyclin-dependent kinase 6 |
20 |
17 |
Small-scale |
0.991 | High |
|
REL
Proto-oncogene c-Rel |
3 |
9 |
High-throughput |
0.881 | High |
|
VINEX
Vinexin |
2 |
18 |
High-throughput |
0.783 | High |
|
ANR44
Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B |
3 |
16 |
High-throughput |
0.770 | High |
|
CDN2B
Cyclin-dependent kinase 4 inhibitor B |
2 |
15 |
High-throughput |
0.768 | High |
|
ATM
Serine-protein kinase ATM |
1 |
8 |
Small-scale |
0.724 | High |
|
ATR
Serine/threonine-protein kinase ATR |
1 |
7 |
Small-scale |
0.724 | High |
|
P53
Cellular tumor antigen p53 |
1 |
12 |
High-throughput |
0.698 | High |
|
SAHH2
S-adenosylhomocysteine hydrolase-like protein 1 |
5 |
0 |
High-throughput |
0.694 | High |
|
ITF2
Transcription factor 4 |
3 |
2 |
High-throughput |
0.683 | High |
|
HTF4
Transcription factor 12 |
3 |
2 |
High-throughput |
0.683 | High |
|
NAGK
N-acetyl-D-glucosamine kinase |
3 |
1 |
High-throughput |
0.683 | High |
|
CCND1
G1/S-specific cyclin-D1 |
3 |
12 |
High-throughput |
0.667 | High |
|
CCND3
G1/S-specific cyclin-D3 |
3 |
12 |
High-throughput |
0.667 | High |
|
NIF3L
NIF3-like protein 1 |
2 |
2 |
High-throughput |
0.654 | High |
|
RAF1
RAF proto-oncogene serine/threonine-protein kinase |
1 |
13 |
High-throughput |
0.647 | High |
|
ERBB2
Receptor tyrosine-protein kinase erbB-2 |
1 |
20 |
High-throughput |
0.647 | High |
|
PGFRA
Platelet-derived growth factor receptor alpha |
1 |
20 |
High-throughput |
0.647 | High |
|
AKT1
RAC-alpha serine/threonine-protein kinase |
1 |
10 |
High-throughput |
0.647 | High |
|
MK08
Mitogen-activated protein kinase 8 |
1 |
15 |
Small-scale |
0.647 | High |
|
MP2K3
Dual specificity mitogen-activated protein kinase kinase 3 |
1 |
20 |
High-throughput |
0.647 | High |
|
MK10
Mitogen-activated protein kinase 10 |
1 |
15 |
Small-scale |
0.647 | High |
|
STK11
Serine/threonine-protein kinase STK11 |
1 |
2 |
High-throughput |
0.647 | High |
|
LATS2
Serine/threonine-protein kinase LATS2 |
1 |
12 |
High-throughput |
0.647 | High |
|
CASP6
Caspase-6 |
1 |
0 |
High-throughput |
0.630 | High |
|
COKA1
|
1 |
14 |
High-throughput |
0.618 | High |
|
MK01
Mitogen-activated protein kinase 1 |
1 |
10 |
High-throughput |
0.618 | High |
|
CDN2D
Cyclin-dependent kinase 4 inhibitor D |
1 |
20 |
High-throughput |
0.618 | High |
|
TRI67
Tripartite motif-containing protein 67 |
1 |
20 |
High-throughput |
0.618 | High |
|
GA2L1
GAS2-like protein 1 |
2 |
8 |
High-throughput |
0.611 | High |
|
CRX
Cone-rod homeobox protein |
2 |
15 |
High-throughput |
0.606 | High |
|
PO6F2
POU domain, class 6, transcription factor 2 |
2 |
7 |
High-throughput |
0.606 | High |
|
K1H1
Keratin, type I cuticular Ha1 |
2 |
12 |
High-throughput |
0.606 | High |
|
PKHG4
Puratrophin-1 |
2 |
10 |
High-throughput |
0.606 | High |
|
PBX4
Pre-B-cell leukemia transcription factor 4 |
2 |
1 |
High-throughput |
0.606 | High |
|
CTDS1
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 |
2 |
3 |
High-throughput |
0.606 | High |
|
NEU2
Vasopressin-neurophysin 2-copeptin |
2 |
0 |
High-throughput |
0.602 | High |
|
CDD
Cytidine deaminase |
2 |
0 |
High-throughput |
0.602 | High |
|
PYM1
Partner of Y14 and mago |
2 |
0 |
High-throughput |
0.602 | High |
|
FGFR4
Fibroblast growth factor receptor 4 |
1 |
20 |
High-throughput |
0.579 | High |
|
EPHA2
Ephrin type-A receptor 2 |
1 |
20 |
High-throughput |
0.579 | High |
|
MP2K5
Dual specificity mitogen-activated protein kinase kinase 5 |
1 |
19 |
High-throughput |
0.579 | High |
|
PRSR2
Proline and serine-rich protein 2 |
2 |
1 |
High-throughput |
0.574 | High |
|
CYLD
Ubiquitin carboxyl-terminal hydrolase CYLD |
1 |
2 |
Small-scale |
0.561 | High |
|
GDF9
Growth/differentiation factor 9 |
1 |
2 |
High-throughput |
0.541 | High |
|
ARY2
Arylamine N-acetyltransferase 2 |
1 |
1 |
High-throughput |
0.541 | High |
|
NH2L1
NHP2-like protein 1 |
1 |
1 |
High-throughput |
0.541 | High |
|
PP2AA
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
1 |
11 |
High-throughput |
0.541 | High |
|
TLE1
Transducin-like enhancer protein 1 |
1 |
6 |
High-throughput |
0.541 | High |
|
U119A
Protein unc-119 homolog A |
1 |
2 |
High-throughput |
0.541 | High |
|
CSN6
COP9 signalosome complex subunit 6 |
1 |
3 |
High-throughput |
0.541 | High |
|
MTA3
Metastasis-associated protein MTA3 |
1 |
13 |
High-throughput |
0.541 | High |
|
GOPC
Golgi-associated PDZ and coiled-coil motif-containing protein |
1 |
20 |
High-throughput |
0.541 | High |
|
EZH2
Histone-lysine N-methyltransferase EZH2 |
1 |
18 |
High-throughput |
0.536 | High |
|
RIN3
Ras and Rab interactor 3 |
1 |
9 |
High-throughput |
0.536 | High |
|
GPSM3
G-protein-signaling modulator 3 |
1 |
1 |
High-throughput |
0.536 | High |
|
NC2A
Dr1-associated corepressor |
1 |
0 |
High-throughput |
0.518 | High |
|
HIP1
Huntingtin-interacting protein 1 |
1 |
6 |
High-throughput |
0.515 | High |
|
PR40A
Pre-mRNA-processing factor 40 homolog A |
1 |
13 |
High-throughput |
0.515 | High |
|
A4
Amyloid-beta precursor protein |
1 |
6 |
High-throughput |
0.515 | High |
|
ACOX1
Peroxisomal acyl-coenzyme A oxidase 1 |
1 |
0 |
High-throughput |
0.513 | High |
|
SPXN
Spexin |
1 |
0 |
High-throughput |
0.513 | High |
|
BEX4
Protein BEX4 |
1 |
0 |
High-throughput |
0.513 | High |
|
LNX2
Ligand of Numb protein X 2 |
1 |
20 |
High-throughput |
0.512 | High |
|
MYC
Myc proto-oncogene protein |
1 |
17 |
High-throughput |
0.501 | High |
|
UBC
Polyubiquitin-C [Cleaved into: Ubiquitin] |
1 |
14 |
High-throughput |
0.501 | High |
|
CCNE1
G1/S-specific cyclin-E1 |
1 |
3 |
High-throughput |
0.501 | High |
|
ARNT
Aryl hydrocarbon receptor nuclear translocator |
1 |
7 |
High-throughput |
0.501 | High |
|
CCND2
G1/S-specific cyclin-D2 |
1 |
9 |
High-throughput |
0.501 | High |
|
MERL
Merlin |
1 |
20 |
High-throughput |
0.501 | High |
|
GRM1
Metabotropic glutamate receptor 1 |
1 |
3 |
High-throughput |
0.501 | High |
|
APLP1
Amyloid beta precursor like protein 1 |
1 |
6 |
High-throughput |
0.494 | High |
|
ANGL4
Angiopoietin-related protein 4 |
1 |
2 |
High-throughput |
0.494 | High |
|
CC90B
Coiled-coil domain-containing protein 90B, mitochondrial |
1 |
1 |
High-throughput |
0.494 | High |
|
ST14
Suppressor of tumorigenicity 14 protein |
1 |
1 |
High-throughput |
0.494 | High |
|
PPM1J
Protein phosphatase 1J |
1 |
1 |
High-throughput |
0.489 | High |
|
SYMM
Methionine--tRNA ligase, mitochondrial |
1 |
2 |
High-throughput |
0.489 | High |
|
AT7L1
Ataxin-7-like protein 1 |
1 |
10 |
High-throughput |
0.489 | High |
|
CDN2A
Cyclin-dependent kinase inhibitor 2A |
1 |
16 |
High-throughput |
0.479 | High |
|
KAD2
Adenylate kinase 2, mitochondrial |
1 |
6 |
High-throughput |
0.479 | High |
|
CDC37
Hsp90 co-chaperone Cdc37 |
1 |
6 |
High-throughput |
0.479 | High |
|
UBQL2
Ubiquilin-2 |
1 |
8 |
High-throughput |
0.479 | High |
|
LAMP2
Lysosome-associated membrane glycoprotein 2 |
1 |
5 |
High-throughput |
0.470 | High |
|
MTMRE
Myotubularin-related protein 14 |
1 |
0 |
High-throughput |
0.458 | High |
|
RIF1
Telomere-associated protein RIF1 |
1 |
18 |
High-throughput |
0.457 | High |
|
SLX1
Structure-specific endonuclease subunit SLX1 |
2 |
0 |
High-throughput |
0.328 | High |
|
SG2A2
Mammaglobin-A |
1 |
0 |
High-throughput |
0.282 | High |
|
GREB1
Protein GREB1 |
1 |
0 |
High-throughput |
0.282 | High |
|
RBM48
RNA-binding protein 48 |
1 |
0 |
High-throughput |
0.282 | High |
|
LY96
Lymphocyte antigen 96 |
1 |
0 |
High-throughput |
0.282 | High |
|
GIP
Gastric inhibitory polypeptide |
1 |
0 |
High-throughput |
0.279 | Low |
|
CART
|
1 |
0 |
High-throughput |
0.279 | Low |
|
DAAF8
Dynein axonemal assembly factor 8 |
1 |
0 |
High-throughput |
0.279 | Low |
|
LRIF1
Ligand-dependent nuclear receptor-interacting factor 1 |
1 |
0 |
High-throughput |
0.251 | Low |
|
QPCTL
Glutaminyl-peptide cyclotransferase-like protein |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024